Skip to content

Trochanteric Bursal Repair After a Total Hip Replacement - Are There Benefits During the First 90 Days

Trochanteric Bursal Repair After a Total Hip Replacement - Are There Benefits During the First 90 Days

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06553508
Enrollment
104
Registered
2024-08-14
Start date
2022-01-01
Completion date
2023-01-01
Last updated
2024-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bursa; Tuberculous, Deep Gluteal Syndrome, Hip Bursitis, Hip Disease

Keywords

bursa, greater trochanter, hip arthroplasty, deep gluteal syndrome, piriformis syndrome

Brief summary

During total hip arthroplasty surgery, the trochanteric bursa is routinely excised. This anatomical structure, which functions as a soft tissue barrier, is generally recommended for removal as it facilitates the surgical approach. However, recent studies have suggested that the trochanteric bursa is an important soft tissue barrier and may protect against infections. The aim of this study is to evaluate the differences in infection rates, wound complications, deep gluteal syndrome presence, pain, and clinical scores within the first 90 days between patients in whom the trochanteric bursa was repaired and those in whom it was not, and to provide recommendations regarding bursal repair.

Detailed description

During total hip arthroplasty surgery, the trochanteric bursa is routinely excised. This anatomical structure, which functions as a soft tissue barrier, is typically recommended for removal as it facilitates the surgical approach. However, recent studies have suggested that the trochanteric bursa is an important soft tissue barrier and may provide protection against infections. The aim of this study is to evaluate the differences in infection rates, wound complications, deep gluteal syndrome presence, pain, and clinical scores within the first 90 days between patients in whom the trochanteric bursa was repaired and those in whom it was not, and to provide recommendations regarding bursal repair. This research will be a prospective randomized controlled trial with patients subjected to sequential randomization. One group of patients will undergo the routine excision of the bursa during surgery, referred to as Group 1. In the other group, the trochanteric bursa will be carefully retracted and subsequently repaired in its anatomical location beneath the fascia after the surgical procedure. Wound closure will be performed routinely, with subcutaneous and skin closure. All patients will have a Hemovac drain placed, and they will follow the same rehabilitation protocol. Patients will be evaluated on postoperative days15, 30, and 90 using Visual Analog Scale scores, and on days 30 and 90 using the Harris Hip Score. Additionally, patients will be assessed for tenderness on palpation, the presence of hip snapping (a sensation of the hip catching), hemoglobin drop, 90-day infection rates, and the presence of deep gluteal syndrome.

Interventions

PROCEDURETrochanteric bursa repaired

As a routine procedure in our centre, the trochanteric bursa is left unrepaired after a hip arthroplasty.

PROCEDURETrochanteric bursa unrepaired

For the experimental arm, the trochanteric bursa is repaired after a hip arthroplasty. The conventional joint closure is performed after reduction and then the bursa is retrieved and repaired.

Sponsors

Ankara City Hospital Bilkent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients between 18 to 90 years of age * With a diagnosis of primary hip osteoarthritis * Willing to be included in the study

Exclusion criteria

* Patients who had a known history of trochanteric bursitis, deep gluteal syndrome, sciatica, vertebral fracture, hip fracture, hip arthroscopy, and core decompression surgery * Patients who had a history of bursal injection within 6 months * Patients undergoing hip arthroplasty with a shortening osteotomy

Design outcomes

Primary

MeasureTime frameDescription
Rate of superficial wound problemsFirst postoperative 90 daysWound leakage, superficial infection, wound dehiscence - Recorded as Yes / No
Rate of posterior gluteal painFirst postoperative 90 daysThe condition is also refered to as Deep Gluteal Syndrome - Recorded as Yes / No
Rate of painful trochanteric bursitisFirst postoperative 90 daysRecorded as pain on the trochanteric region on palpation - Recorded as Yes / No

Secondary

MeasureTime frameDescription
Range of motion (ROM)First postoperative 90 daysAngular measurement of hip joint motion - minimum value:0, maximum value 130, higher values mean better outcome
Visual Analog Scale (VAS)First postoperative 90 daysminimum value:0, maximum value 10, higher values mean worse outcome
Harris Hip Score (HHS)First postoperative 90 daysminimum value:0, maximum value 100, higher values mean better outcome

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026